NYU Langone Orthopedics has established itself as a national leader in patient safety metrics, consistently maintaining some of the lowest rates of hospital acquired conditions (HACs) and hospital-acquired venous thromboembolism (VTE) in the nation.
“These results speak to our ability to operationalize high standards across every patient touchpoint,” says Joseph A. Bosco III, MD, director of quality and patient safety in the Department of Orthopedic Surgery. “Maintaining outstanding clinical outcomes is central to patient trust and system-wide excellence.”
“These outstanding metrics are not only a reflection of individual excellence, but of a system that empowers teams to deliver world-class care, safely and consistently.”
Joseph A. Bosco III, MD
The department’s success stems from its investment in data-driven decision-making as well as a multifaceted quality improvement framework that emphasizes proactive risk assessment, rigorous protocol adherence, and real-time monitoring. This approach has supported excellent patient outcomes year after year, even as NYU Langone Orthopedics has expanded its services and patient volume.
“These outstanding metrics are not only a reflection of individual excellence, but of a system that empowers teams to deliver world-class care, safely and consistently,” says Dr. Bosco. “As we continue to expand and innovate, our focus on quality and patient outcomes remains unwavering.”
